- Home
- ESPR vs ATNI Comparison
ESPR vs ATNI Comparison
Compare ESPR & ATNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- ATNI
- Stock Information
- Founded
- ESPR 2008
- ATNI 1987
- Country
- ESPR United States
- ATNI United States
- Employees
- ESPR N/A
- ATNI N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- ATNI Telecommunications Equipment
- Sector
- ESPR Health Care
- ATNI Telecommunications
- Exchange
- ESPR Nasdaq
- ATNI Nasdaq
- Market Cap
- ESPR 208.1M
- ATNI 240.0M
- IPO Year
- ESPR 2013
- ATNI 1991
- Fundamental
- Price
- ESPR $1.01
- ATNI $16.34
- Analyst Decision
- ESPR Buy
- ATNI Strong Buy
- Analyst Count
- ESPR 7
- ATNI 1
- Target Price
- ESPR $5.93
- ATNI $30.00
- AVG Volume (30 Days)
- ESPR 3.5M
- ATNI 47.4K
- Earning Date
- ESPR 08-11-2025
- ATNI 07-23-2025
- Dividend Yield
- ESPR N/A
- ATNI 6.01%
- EPS Growth
- ESPR N/A
- ATNI N/A
- EPS
- ESPR N/A
- ATNI N/A
- Revenue
- ESPR $259,574,000.00
- ATNI $721,575,000.00
- Revenue This Year
- ESPR $4.07
- ATNI $2.03
- Revenue Next Year
- ESPR N/A
- ATNI $1.59
- P/E Ratio
- ESPR N/A
- ATNI N/A
- Revenue Growth
- ESPR 12.99
- ATNI N/A
- 52 Week Low
- ESPR $0.69
- ATNI $13.76
- 52 Week High
- ESPR $3.94
- ATNI $33.72
- Technical
- Relative Strength Index (RSI)
- ESPR 46.78
- ATNI 58.94
- Support Level
- ESPR $0.99
- ATNI $15.89
- Resistance Level
- ESPR $1.10
- ATNI $16.66
- Average True Range (ATR)
- ESPR 0.07
- ATNI 0.51
- MACD
- ESPR -0.02
- ATNI 0.12
- Stochastic Oscillator
- ESPR 10.71
- ATNI 90.13
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About ATNI ATN International Inc.
ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise U.S. Telecom and International Telecom. The company earns revenue from its International telecommunication segment.